Nanoform Finland
1.762 EUR 0%3,425 investors are following this company
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
NANOFH
Daily low / high price
1.742 / 1.796
EUR
Market cap
150.7M EUR
Turnover
17.61K EUR
Volume
9.9K
Latest videos
Financial calendar
Interim report
29.08.2024
Interim report
22.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Handelsbanken | 7.5 % | 7.5 % |
Edward Hæggström | 6.9 % | 6.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Nanoform Finland Plc - Manager's Transactions - Mads Laustsen
Nanoform Finland Plc - Manager's Transactions - Albert Hæggström
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools